Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex for Retinal Vein Occlusion (ORVO)
NCT01790685Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ozurdex in macular edema, sponsored by Johns Hopkins University. Started Feb 2013; status: completed.
02
Drugs
ozurdex
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT01790685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790685.